| Pharmaceutical active ingredients: |
| ClioquinolNystatin |
| Available forms, composition and doses of Nystaform: |
| Ointment; Topical; Clioquinol 10 mg; Nystatin 100,000 units / g |
| Nystaform medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G01AA51 - Nystatin, combinationsP01AA52 - Clioquinol, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nujol | Mineral Oil | Bayer Schering Pharma; Fumouze Laboratoires; Schering-Plough |
| Nur-Isterate | Norethindrone Enanthate | Bayer Schering Pharma |
| Nuvelle | Estradiol Valerate; Levonorgestrel | Bayer Schering Pharma; HE Clissmann; Shepa |
| Nuvelle Continuous | Estradiol Hemihydrate; Norethindrone Acetate | Bayer Schering Pharma |
| Nuvelle TS | Estradiol; Levonorgestrel | Bayer Schering Pharma; Farmades |
| Nystaform Cream | Chlorhexidine Hydrochloride; Nystatin | Bayer Schering Pharma; Typharm |
| Nystaform-HC | Chlorhexidine Acetate; Chlorhexidine Hydrochloride; Hydrocortisone; Nystatin | Bayer Schering Pharma; Typharm |
| Oberon | Spiromesifen | Bayer Schering Pharma |
| Octegra | Moxifloxacin Hydrochloride | Bayer Schering Pharma; Bago Laboratorios; Elpen; Grupo Vita / Vita Cientifica; Recordati |
| Octocog Alpha | Coagulation Factor VIII | Bayer Schering Pharma |